Trials
Search / Trial NCT06417515

The Potential Benefit of Xiao-Yao-San Treatment in Patients With Insomnia

Launched by YU-CHING HSU · May 12, 2024

Trial Information

Current as of February 19, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 20- to 65-year-old patients.
  • Pittsburgh Sleep Quality Index (PSQI) scores ≥ 5.
  • Exclusion Criteria:
  • Schizophrenia.
  • Narcolepsy.
  • Neurological diseases (history of stroke, neurodegenerative diseases, etc.).
  • Alcohol addiction.
  • Drug addiction.

Trial Officials

YU-CHING HSU

Principal Investigator

Tainan Hospital, Ministry of Health and Welfare

About Yu Ching Hsu

Yu-Ching Hsu is a dedicated clinical trial sponsor focused on advancing medical research and innovative therapies. With a robust commitment to improving patient outcomes, Hsu leads initiatives that prioritize safety, efficacy, and ethical standards in clinical trials. By collaborating with diverse stakeholders, including healthcare professionals and regulatory agencies, Yu-Ching Hsu aims to accelerate the development of groundbreaking treatments while ensuring compliance with industry best practices. Through meticulous oversight and a patient-centered approach, Hsu strives to contribute valuable insights to the medical community and enhance the quality of care for patients worldwide.

Locations

Tainan, , Taiwan

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0